UNITAID publish CEPA review of project aimed at scaling-up access to a rapid TB diagnostic tool

Home > News Archive > UNITAID publish CEPA review of project aimed at scaling-up access to a rapid TB diagnostic tool
23rd November 2015

CEPA was appointed to carry out a mid-term review of a UNITAID-funded project that aims to support the scale-up of rapid diagnosis of TB, HIV-associated TB and drug-resistant TB through the increased uptake of Xpert MTB/RIF. Xpert MTB/RIF is a breakthrough TB diagnostic tool, manufactured by Cepheid and recommended for use by WHO to simultaneously detect TB and rifampicin drug resistance in less than two hours. The project is being implemented by the WHO Global TB Program and the Stop TB Partnership/ TB REACH initiative. 

The full report is available here.